The ESMINT Research Committee is conducting a survey on current practices in antithrombotic management for carotid artery stenting in patients with atrial fibrillation. This topic is of particular importance due to the delicate balance between stroke prevention and bleeding risk in this patient group.
Why Your Participation Matters
Patients with atrial fibrillation are at an increased risk of stroke, requiring anticoagulation therapy. However, carotid artery stenting procedures also pose a risk of bleeding complications. Finding the optimal antithrombotic strategy remains a challenge, and gathering expert insights is essential for developing standardized protocols and improving patient outcomes.
Survey Details
- Time required: Less than 10 minutes
- Anonymity: All responses are confidential
- Deadline: May 15, 2025
Your expertise can help shape future recommendations in neurointerventional care.
Take the survey now:
PARTICIPATE NOWFor any questions, feel free to contact us. Thank you for your valuable contribution!
Sincerely,
Jacopo Scaggiante, Riccardo Caronna, Simona Gaudino, Tommaso Villa, Giuseppe Varcasia, Rosetta Melfi, Mais Al-Kawaz, Giovanni Frisullo, Johanna Fifi and the Research Committee of the European Society of Minimally Invasive Neurological Therapy (ESMINT)
